Canna Law Blog

APRIL 24, 2023

Both Oregon and California (and now Washington) have THC program export bills, but those laws are anticipatory and mostly symbolic. Neither California nor Washington – nor any other state with a closed-loop, “marijuana” program – allows for licensee shipments interstate. See our thoughts here and here ). Will SB 353 pass?

Hemp 72

Hemp Seed-To-Sale Marijuana Cannabinoids 72

Cannabis Law Report

MAY 29, 2022

Celebrated author Michael Pollan has published two bestselling books on the topic: How to Change Your Mind and This is Your Mind on Plants. 8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. 20, 2020), [link]. [8] 5, 2019), [link]. [9]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Canna Law Blog

JANUARY 3, 2023

To date, while taking input from the public on the topic, the FDA mostly has engaged in enforcement, sometimes in tandem with Federal Trade Commission (“FTC”), against CBD retailers. For years everyone has wondered when, or even if , the FDA would propose and adopt CBD regulations.

CBD 75

CBD Food Clinical Trials Pets 75

Veriheal

AUGUST 24, 2022

If passed, the Department of Regulatory Agencies would be required to develop rules that would allow for therapeutic psychedelic programs at licensed healing centers for adults to receive psychedelic treatments by a trained facilitator.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Canna Law Blog

AUGUST 30, 2020

However, this (1) did not offer any help for hemp cultivated in states with hemp programs that were inconsistent with the 2014 Farm Bill, and (2) is only guidance and was not legally binding on any court or law enforcement agency. We will be sure to continue writing on this topic, so stay tuned to the Canna Law Blog.

Hemp 98

Hemp Agriculture Extraction THC 98

SMPL

AUGUST 14, 2019

While the House approved a budget rider that would extend protections to adult-use programs , it’s not clear how that will fare in the Senate—and even if it passes, it must be annually renewed, creating uncertainty. One area that could be quickly improved is in the sourcing of research-grade marijuana.

Policy 40

Policy Research and Development Marijuana DEA 40

The Blunt Truth

DECEMBER 26, 2019

January proved that there’s always a cannabis angle, no matter what the topic of conversation. In October, Senator Mitch McConnell directed the DEA to figure out how to distinguish hemp from marijuana. In tribute to Dave Barry and his always hilarious Year in Review , we’ll organize these stories by month.

Banking 71

Banking Hemp Agriculture Seed-To-Sale 71

Cannabis Law Report

MARCH 3, 2022

Former President Bill Clinton has apparently been hearing a lot about the therapeutic potential of CBD products for pain management lately, and, according to a now-deleted media report, said at a recent conference appearance that broad interest in the topic should spur regulators to develop standards for the cannabinoid.

Media 52

Media CBD Events THC 52

Canna Law Blog

SEPTEMBER 6, 2023

Many people in the cannabis industry are convinced that this HHS recommendation to the Drug Enforcement Administration (DEA) means that the DEA will undertake this rescheduling (and fairly quickly, too–which would be a huge departure from its refusal to reschedule back in 2016). Just my two cents; feel free to disagree.

Research and Development 113

Research and Development DEA Marijuana Pharmaceutical 113

Otherside Farms

AUGUST 4, 2020

You could look ay business management, cultivation, design, marketing, financial services, activism, security, computer programming, and content creation. Banks have not been fond of supporting dispensaries in the fear that funds may get frozen by DEA or the feds. Your business plan lays the groundwork for your future success.

Business 52

Business Banking Dispensary Research and Development 52

Cannabis Law Report

JUNE 1, 2021

“Our cost savings program is on track to deliver $150 – $200 million of savings within the next 18 months, and we remain committed to our path to profitability by the end of Fiscal 2022, while continuing to invest in an organization that is focused on insights, innovation and gaining momentum in the U.S.

Data 95

Data Vaping Supply Chain Business 95

CannaMD

SEPTEMBER 10, 2020

This stems from the fact that despite the ongoing legalization of both recreational and medical marijuana at the state level, cannabis is still classified as a Schedule I substance by the DEA, along with substances such as heroin, cocaine, opioids and methamphetamine.

Marijuana 59

Marijuana Therapy Data THC 59

Cannabis Law Report

NOVEMBER 2, 2021

Based on our analysis, there are currently around 160 companies selling delta-8 THC products online, with more than 4,200 unique products for sale, including edibles, concentrates, vapes, flower, prerolls, tinctures, topicals and beverages. The second argument is based on a DEA interim final rule on the topic of synthetic THC.

THC 96

THC CBD Legalization Vaping 96

Project CBD

AUGUST 23, 2023

23 Yet this conversion is occurring without regulatory oversight to ensure process standardization, product specification, and accurate third-party testing, all of which are mandated in state-licensed cannabis programs. 22 These non-natural THC-like isomers are difficult to measure and almost impossible to remove from the end product.

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Cannabis Law Report

JULY 1, 2021

In the following interview, which has been edited and condensed, Senior Fellow and POPLAR Project Lead Mason Marks explains how POPLAR will fill this gap, and previews some of the initiative’s topics of inquiry. Chloe Reichel: Can you describe the primary goals of POPLAR?

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and CBD are most commonly used via inhalation, ingestion, and topical absorption. 17 Topical cannabis is applied to, and absorbed through, the skin in a cream or salve form. 19 Topical administration of cannabis or cannabinoids has variable onset and duration. Cannabis sativa with less than 0.3%

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Meadow

JULY 13, 2018

The panel covered a wide range of topics local regulators are currently dealing with, including reconciling local and state regulations, enforcement of illicit businesses, license caps, equity and diversity, delivery, onsite consumption, and, of course, taxes. I think over the long term, taxes are going to remain a very important topic.

Wellness and Beauty 40

Wellness and Beauty Consumption Policy Cannabis 40

The Cannigma

SEPTEMBER 12, 2021

Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. Many states that disagreed with the federal approach to cannabis started their own medical marijuana programs, and made it accessible for patients. The THC is extracted from the plant and the rest is discarded.

THC 98

THC Research and Development Cannabinoids CBD 98

Cannabis Law Report

AUGUST 6, 2021

including building inventory and activating new production capacity along with higher third-party shipping, distribution and warehousing costs, partially offset by payroll subsidies received from the Canadian government in Q1 2022, pursuant to a COVID-19 relief program. Beverages, edibles, topicals 7. and vapes. Excise taxes.

Vaping 105

Vaping Research and Development Data Business 105

The Cannigma

FEBRUARY 16, 2022

I love the fact that we’re really starting to lean into this more because I think it’s a topic that deserves attention. So, we are partnering with the Harrington Institute to provide two different cohorts here in Chicago, program we have going on. One cohort is specializing in essentially a reentry program.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse. Some states that have passed recreational or medical marijuana legislation are still negotiating the details for implementing these programs. each year since 2019.

Recreational 52

Recreational Data Cannabis DEA 52

Canna Law Blog

NOVEMBER 16, 2021

The enforcement role moves from DEA to ATF. When it comes to enforcing federal cannabis regulations, the Drug Enforcement Administration (“DEA”) is out and the Bureau of Alcohol, Tobacco, Firearms, and Explosives (“ATF”) is in (in addition to TTB as the primary overseer). Age limits (21). ” SBA fairness.

DEA 88

DEA Business Banking Food 88

SpeedWeed

APRIL 1, 2021

Fried remembers the debate, featuring a then- High Times editor and a DEA agent, marking the first substantive cannabis conversation during her time at school. . Since 2014, the state has made incremental progress, first legalizing CBD oil, then expanding its medical program in 2016.

Agriculture 52

Agriculture Policy THC Cannabis 52

Cannabis Law Report

JUNE 25, 2021

Drug Enforcement Agency (DEA)’s narcotic drug schedule as defined by the Controlled Substances Act (CSA). While the FDA doesn’t have age restrictions in place for uses of CBD like topicals and oils, it does suggest that that any smokable flower or vaping oils be sold only to individuals aged 18 and older.

Banking 66

Banking CBD Hemp Seed-To-Sale 66

Cannabis Law Report

JULY 30, 2019

The informed patients, cannabis industry employees, and clinicians find it equally difficult to keep updated on Florida’s latest medical marijuana program news and changes. . Cannabis is not a “gateway” drug, according to the ASA and the DEA’s own statements cited in the August 2016 U.S. Federal Register. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

JULY 14, 2021

The proposed plan would also establish a regulatory framework for state-legal cannabis businesses, expunge non-violent cannabis convictions, and create programs to support small and minority-owned cannabis businesses while reinvesting resources in the communities that have been disproportionately harmed by prohibition. Ganjapreneur.

Legislation 71

Legislation Banking History Access 71

The Blunt Truth

DECEMBER 31, 2020

In February , marijuana was a topic of conversation at the Democratic Presidential debates. Senator Mitch McConnell (R-KY) objected to including cannabis banking in federal relief programs. The DEA released an interim hemp rule that the industry hated. And the DEA’s hemp rule brought on litigation.

DEA 109

DEA Decriminalization Hemp Banking 109